Literature DB >> 3026338

The effect of phospholipids on the activation of protein C by the human thrombin-thrombomodulin complex.

J M Freyssinet, J Gauchy, J P Cazenave.   

Abstract

Human thrombomodulin, an endothelial-cell-membrane glycoprotein, has been purified from placenta by Triton X-100 extraction and by affinity chromatography on concanavalin A-Sepharose and thrombin-Sepharose. It has been characterized by its ability to promote the activation of human protein C by human alpha-thrombin in the presence of Ca2+ and fulfilled the requirements of a cofactor. Reconstitution of thrombomodulin into phospholipid vesicles containing anionic phospholipids resulted in an increased rate of activation of protein C. Cardiolipin and vesicles containing phosphatidylcholine/phosphatidylserine (1:1, w/w) were the most effective. The apparent Km of the thrombin-thrombomodulin complex for protein C was 2 microM. It was not changed in the presence of phospholipid, whereas the Vmax. could be apparently increased up to 3.2-fold depending on the phospholipid and on its concentration, the catalytic-centre activity reaching 15.7 mol of activated protein C formed/min per mol of thrombin. Above their optimal concentrations, phospholipids inhibited the amidolytic activity of activated protein C. Phospholipids had no effect on the activation of 4-carboxyglutamic acid-domainless protein C, a proteolytic derivative of protein C lacking the 4-carboxyglutamic acid residues. These results show that the positive effect of anionic phospholipids in the activation of protein C by the thrombin-thrombomodulin complex involves a Ca2+-dependent interaction between protein C and phospholipids. They suggest that the enhancement of thrombomodulin activity by such phospholipids may be of functional significance.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3026338      PMCID: PMC1147109          DOI: 10.1042/bj2380151

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  27 in total

Review 1.  Membrane and lipid involvement in blood coagulation.

Authors:  R F Zwaal
Journal:  Biochim Biophys Acta       Date:  1978-07-31

Review 2.  Biochemistry of blood coagulation.

Authors:  M P Esnouf
Journal:  Br Med Bull       Date:  1977-09       Impact factor: 4.291

Review 3.  Vitamin K-dependent formation of gamma-carboxyglutamic acid.

Authors:  J Stenflo; J W Suttie
Journal:  Annu Rev Biochem       Date:  1977       Impact factor: 23.643

4.  Preparation of homogeneous, single-walled phosphatidylcholine vesicles.

Authors:  C Huang; T E Thompson
Journal:  Methods Enzymol       Date:  1974       Impact factor: 1.600

Review 5.  Liposomes-as artificial organelles, topochemical matrices, and therapeutic carrier systems.

Authors:  P Nicholls
Journal:  Int Rev Cytol Suppl       Date:  1981

6.  Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C.

Authors:  C T Esmon; W G Owen
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

Review 7.  Blood coagulation.

Authors:  C M Jackson; Y Nemerson
Journal:  Annu Rev Biochem       Date:  1980       Impact factor: 23.643

8.  Thrombomodulin is present in human plasma and urine.

Authors:  H Ishii; P W Majerus
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

9.  Human thrombins. Production, evaluation, and properties of alpha-thrombin.

Authors:  J W Fenton; M J Fasco; A B Stackrow
Journal:  J Biol Chem       Date:  1977-06-10       Impact factor: 5.157

10.  Coextraction of thrombomodulin and tissue factor from human placenta: effects of concanavalin A and phospholipid environment on activity.

Authors:  J M Freyssinet; B Brami; J Gauchy; J P Cazenave
Journal:  Thromb Haemost       Date:  1986-02-28       Impact factor: 5.249

View more
  12 in total

1.  Stability of the thrombin-thrombomodulin complex on the surface of endothelial cells from human saphenous vein or from the cell line EA.hy 926.

Authors:  A Beretz; J M Freyssinet; J Gauchy; D A Schmitt; C Klein-Soyer; C J Edgell; J P Cazenave
Journal:  Biochem J       Date:  1989-04-01       Impact factor: 3.857

2.  Role of beta 2-glycoprotein I and anti-phospholipid antibodies in activation of protein C in vitro.

Authors:  D M Keeling; A J Wilson; I J Mackie; D A Isenberg; S J Machin
Journal:  J Clin Pathol       Date:  1993-10       Impact factor: 3.411

3.  Prevalence and significance of anticardiolipin antibodies in Crohn's disease.

Authors:  P Chamouard; L Grunebaum; M L Wiesel; J M Freyssinet; B Duclos; J P Cazenave; R Baumann
Journal:  Dig Dis Sci       Date:  1994-07       Impact factor: 3.199

4.  Fasting lipids and anticardiolipin antibodies as risk factors for vascular disease in systemic lupus erythematosus.

Authors:  A J MacGregor; V B Dhillon; A Binder; C A Forte; B C Knight; D J Betteridge; D A Isenberg
Journal:  Ann Rheum Dis       Date:  1992-02       Impact factor: 19.103

5.  Activation of human protein C by blood coagulation factor Xa in the presence of anionic phospholipids. Enhancement by sulphated polysaccharides.

Authors:  J M Freyssinet; M L Wiesel; L Grunebaum; J M Pereillo; J Gauchy; S Schuhler; G Freund; J P Cazenave
Journal:  Biochem J       Date:  1989-07-15       Impact factor: 3.857

6.  An acquired antithrombin autoantibody directed toward the catalytic center of the enzyme.

Authors:  P Sié; A Bezeaud; D Dupouy; G Archipoff; J M Freyssinet; J M Dugoujon; G Serre; M C Guillin; B Boneu
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

7.  Screening the molecular surface of human anticoagulant protein C: a search for interaction sites.

Authors:  B O Villoutreix; D G Covell; A M Blom; A Wallqvist; U Friedrich; B Dahlbäck
Journal:  J Comput Aided Mol Des       Date:  2001-01       Impact factor: 3.686

8.  Enhancement of thrombin-thrombomodulin-catalysed protein C activation by phosphatidylethanolamine containing unsaturated fatty acids: possible physiological significance of phosphatidylethanolamine in anticoagulant activity of thrombomodulin.

Authors:  S Horie; H Ishii; H Hara; M Kazama
Journal:  Biochem J       Date:  1994-08-01       Impact factor: 3.857

9.  Interference of blood-coagulation vitamin K-dependent proteins in the activation of human protein C. Involvement of the 4-carboxyglutamic acid domain in two distinct interactions with the thrombin-thrombomodulin complex and with phospholipids.

Authors:  J M Freyssinet; A Beretz; C Klein-Soyer; J Gauchy; S Schuhler; J P Cazenave
Journal:  Biochem J       Date:  1988-12-01       Impact factor: 3.857

10.  The contributions of Ca2+, phospholipids and tissue-factor apoprotein to the activation of human blood-coagulation factor X by activated factor VII.

Authors:  V J Bom; R M Bertina
Journal:  Biochem J       Date:  1990-01-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.